140 related articles for article (PubMed ID: 32079204)
1. Direct Interaction between Calmodulin and the Grb7 RA-PH Domain.
Watson GM; Wilce JA
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079204
[TBL] [Abstract][Full Text] [Related]
2. The adaptor Grb7 is a novel calmodulin-binding protein: functional implications of the interaction of calmodulin with Grb7.
Li H; Sánchez-Torres J; del Carpio AF; Nogales-González A; Molina-Ortiz P; Moreno MJ; Török K; Villalobo A
Oncogene; 2005 Jun; 24(26):4206-19. PubMed ID: 15806159
[TBL] [Abstract][Full Text] [Related]
3. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the calmodulin-binding domain of Grb7 impairs cell attachment to the extracellular matrix and migration.
García-Palmero I; Villalobo A
Biochem Biophys Res Commun; 2013 Jun; 436(2):271-7. PubMed ID: 23743201
[TBL] [Abstract][Full Text] [Related]
6. Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.
Siamakpour-Reihani S; Peterson TA; Bradford AM; Argiros HJ; Haas LL; Lor SN; Haulsee ZM; Spuches AM; Johnson DL; Rohrschneider LR; Shuster CB; Lyons BA
J Mol Recognit; 2011; 24(2):314-21. PubMed ID: 20665473
[TBL] [Abstract][Full Text] [Related]
7. Grb7 protein RA domain oligomerization.
Godamudunage MP; Foster A; Warren D; Lyons BA
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28295715
[TBL] [Abstract][Full Text] [Related]
8. The adaptors Grb10 and Grb14 are calmodulin-binding proteins.
García-Palmero I; Pompas-Veganzones N; Villalobo E; Gioria S; Haiech J; Villalobo A
FEBS Lett; 2017 Apr; 591(8):1176-1186. PubMed ID: 28295264
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin regulates the translocation of Grb7 into the nucleus.
García-Palmero I; Villalobo A
FEBS Lett; 2012 May; 586(10):1533-9. PubMed ID: 22673522
[TBL] [Abstract][Full Text] [Related]
11. Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7.
Pandey A; Liu X; Dixon JE; Di Fiore PP; Dixit VM
J Biol Chem; 1996 May; 271(18):10607-10. PubMed ID: 8631863
[TBL] [Abstract][Full Text] [Related]
12. The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.
Siamakpour-Reihani S; Argiros HJ; Wilmeth LJ; Haas LL; Peterson TA; Johnson DL; Shuster CB; Lyons BA
J Mol Recognit; 2009; 22(1):9-17. PubMed ID: 18853468
[TBL] [Abstract][Full Text] [Related]
13. Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.
Villalobo A; García-Palmero I; Stateva SR; Jellali K
J Pharm Pharm Sci; 2013; 16(2):177-89. PubMed ID: 23958188
[TBL] [Abstract][Full Text] [Related]
14. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
15. The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.
Pias S; Peterson TA; Johnson DL; Lyons BA
Crit Rev Immunol; 2010; 30(3):299-304. PubMed ID: 20370637
[TBL] [Abstract][Full Text] [Related]
16. Dimerization in the Grb7 protein.
Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
[TBL] [Abstract][Full Text] [Related]
18. Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one?
Gunzburg MJ; Ambaye ND; Del Borgo MP; Perlmutter P; Wilce JA
Biopolymers; 2013 Sep; 100(5):543-9. PubMed ID: 23505041
[TBL] [Abstract][Full Text] [Related]
19. Partners of wild type Grb7 and a mutant lacking its calmodulin-binding domain.
García-Palmero I; Shah N; Ali NA; Daly RJ; Wilce JA; Villalobo A
Arch Biochem Biophys; 2020 Jul; 687():108386. PubMed ID: 32360748
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
Scharf PJ; Witney J; Daly R; Lyons BA
Protein Sci; 2004 Sep; 13(9):2541-6. PubMed ID: 15322292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]